These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 29204272

  • 21. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience.
    De Soyza A, Meachery G, Hester KL, Nicholson A, Parry G, Tocewicz K, Pillay T, Clark S, Lordan JL, Schueler S, Fisher AJ, Dark JH, Gould FK, Corris PA.
    J Heart Lung Transplant; 2010 Dec; 29(12):1395-404. PubMed ID: 20810293
    [Abstract] [Full Text] [Related]

  • 22. Burkholderia cepacia genomovar III and Burkholderia vietnamiensis double infection in a cystic fibrosis child.
    Magalhães M, de Britto MC, Vandamme P.
    J Cyst Fibros; 2002 Dec; 1(4):292-4. PubMed ID: 15463830
    [Abstract] [Full Text] [Related]

  • 23. Use of ceftazidime/avibactam for the treatment of MDR Pseudomonas aeruginosa and Burkholderia cepacia complex infections in cystic fibrosis: a case series.
    Spoletini G, Etherington C, Shaw N, Clifton IJ, Denton M, Whitaker P, Peckham DG.
    J Antimicrob Chemother; 2019 May 01; 74(5):1425-1429. PubMed ID: 30649419
    [Abstract] [Full Text] [Related]

  • 24. Management and outcomes of Burkholderia cepacia complex bacteremia in patients without cystic fibrosis: a retrospective observational study.
    Lee YM, Park KH, Moon C, Kim DY, Lee MS, Kim T, Choo EJ, Chong YP, Kim SH, Kim YS, Woo JH, Chang MS.
    Eur J Clin Microbiol Infect Dis; 2020 Nov 01; 39(11):2057-2064. PubMed ID: 32583228
    [Abstract] [Full Text] [Related]

  • 25. Activity of Aerosolized Levofloxacin against Burkholderia cepacia in a Mouse Model of Chronic Lung Infection.
    Sabet M, Griffith DC.
    Antimicrob Agents Chemother; 2020 Jan 27; 64(2):. PubMed ID: 31712215
    [Abstract] [Full Text] [Related]

  • 26. Variation of the antimicrobial susceptibility profiles of Burkholderia cepacia complex clonal isolates obtained from chronically infected cystic fibrosis patients: a five-year survey in the major Portuguese treatment center.
    Leitão JH, Sousa SA, Cunha MV, Salgado MJ, Melo-Cristino J, Barreto MC, Sá-Correia I.
    Eur J Clin Microbiol Infect Dis; 2008 Nov 27; 27(11):1101-11. PubMed ID: 18600352
    [Abstract] [Full Text] [Related]

  • 27. Major Aspects of Burkholderia gladioli and Burkholderia cepacia Infections in Children.
    Bedir Demirdag T, Ozkaya Parlakay A, Aygar IS, Gulhan B, Kanik Yuksek S.
    Pediatr Infect Dis J; 2020 May 27; 39(5):374-378. PubMed ID: 32118858
    [Abstract] [Full Text] [Related]

  • 28. Clinical and microbiological profile of chronic Burkholderia cepacia complex infections in a cystic fibrosis reference hospital in Brazil.
    da Costa Capizzani CP, Caçador NC, Torres LAGMM, Tonani L, Vandamme P, da Costa Darini AL.
    Eur J Clin Microbiol Infect Dis; 2017 Nov 27; 36(11):2263-2271. PubMed ID: 28840370
    [Abstract] [Full Text] [Related]

  • 29. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.
    Govan JR, Brown AR, Jones AM.
    Future Microbiol; 2007 Apr 27; 2(2):153-64. PubMed ID: 17661652
    [Abstract] [Full Text] [Related]

  • 30. Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations.
    Coutinho CP, Dos Santos SC, Madeira A, Mira NP, Moreira AS, Sá-Correia I.
    Front Cell Infect Microbiol; 2011 Apr 27; 1():12. PubMed ID: 22919578
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex.
    Fraser-Pitt D, Mercer D, Lovie E, Robertson J, O'Neil D.
    Antimicrob Agents Chemother; 2016 Oct 27; 60(10):6200-6. PubMed ID: 27503654
    [Abstract] [Full Text] [Related]

  • 34. Molecular epidemiology and antibiotic susceptibility of Burkholderia cepacia-complex isolates from an Italian cystic fibrosis centre.
    Golini G, Cazzola G, Fontana R.
    Eur J Clin Microbiol Infect Dis; 2006 Mar 27; 25(3):175-80. PubMed ID: 16501927
    [Abstract] [Full Text] [Related]

  • 35. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Lord R, Jones AM, Horsley A.
    Cochrane Database Syst Rev; 2020 Apr 02; 4(4):CD009529. PubMed ID: 32239690
    [Abstract] [Full Text] [Related]

  • 36. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A, Jones AM, Lord R.
    Cochrane Database Syst Rev; 2016 Jan 20; 2016(1):CD009529. PubMed ID: 26789750
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clonality and Antimicrobial Susceptibility of Burkholderia cepacia complex Isolates Collected from Cystic Fibrosis Patients during 1998-2013 in Bern, Switzerland.
    Lupo A, Isis E, Tinguely R, Endimiani A.
    New Microbiol; 2015 Apr 20; 38(2):281-8. PubMed ID: 25938755
    [Abstract] [Full Text] [Related]

  • 39. Burkholderia cepacia complex: beyond pseudomonas and acinetobacter.
    Gautam V, Singhal L, Ray P.
    Indian J Med Microbiol; 2011 Apr 20; 29(1):4-12. PubMed ID: 21304187
    [Abstract] [Full Text] [Related]

  • 40. Burkholderia cepacia complex: impact on the cystic fibrosis lung lesion.
    Lynch JP.
    Semin Respir Crit Care Med; 2009 Oct 20; 30(5):596-610. PubMed ID: 19760547
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.